Commercial CDMO Companies|
Commercial Contract Manufacturing Services

Your Trusted Partners for Commercial Contract Manufacturing and Development

Applied Filters:Commercial (Phase IV)×Clear All

Showing 149 facilities

Sort by:

India

Jon Paul Selvam

Hikal Ltd.

Hikal is a leading pharma CDMO specializing in small molecules, HPAPIs, process development, custom synthesis, and commercial manufacturing.

Discover our facility

Markets: Health Canada (Canada), ANVISA (Brazil), FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK), CDSCO (India), Turkish Health Authorities, EDE (UAE), SFDA (Saudi Arabia), ANMAT (Argentina), MFDS (South Korea), TGA (Australia), Rest of World

Batch Size: Large, Small, Medium

Use: Human, Veterinary

BSL (Biological Safety Level): 1, 2, 3, 4

Compliance: ISO, ICH, FDA (cGMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), ECOVADIS, World Health Organization (GMP / HACCP), Health Canada (Canada GMP), MHRA (UK GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), PMDA (Japan), ANVISA (Brazil), Health Canada

Therapeutic Areas of Expertise (ATC): (V04) Diagnostic agents, (V09-10) Radiopharmaceuticals, (B) Blood and blood forming organs, (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (S) Sensory organs, (V06) Nutrients, (V01) Allergens, (R) Respiratory system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism

Controlled Substances: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & no medical use, Low potential for abuse, High potential for abuse & medical use

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: SERVICES, CHEMICAL-SYNTHETIC

Region: APAC

Switzerland

CARBOGEN AMCIS | Aarau

CARBOGEN AMCIS

Development and medium scale cGMP manufacturing including chromatography.

Discover our facility

Use: Human, Veterinary

Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), CDSCO (India), MFDS (South Korea), TGA (Australia)

Services: Development services, Analytical / QC services, Manufacturing services, Quality Assurance services

Compliance: ISO, FDA (cGMP), PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP)

Batch Size: Small, Medium

Category / Product: SERVICES, PARTICLE ENGINEERING, BIOLOGICS, CHEMICAL-SYNTHETIC

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Region: Europe

Switzerland

CARBOGEN AMCIS | Vionnaz

CARBOGEN AMCIS

Highly Potent APIs development and small-scale cGMP production including chromatography and lyophilization.

Discover our facility

Services: Development services, Analytical / QC services, Quality Assurance services, Manufacturing services

Markets: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), CDSCO (India), TGA (Australia)

Compliance: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), EMA (EU GMP), World Health Organization (GMP / HACCP)

Use: Human, Veterinary

Batch Size: Small

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Region: Europe

Category / Product: CHEMICAL-SYNTHETIC

France

CARBOGEN AMCIS | Saint-Beauzire

CARBOGEN AMCIS

Custom formulation development and GMP sterile manufacture of liquid and lyophilized drug product.

Discover our facility

Batch Size: Large, Small, Medium

Use: Human

Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), CDSCO (India), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), SFDA (Saudi Arabia), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia), Rest of World

Services: Development services, Analytical / QC services, Regulatory services, Manufacturing services, Quality Assurance services

Compliance: ISO, FDA (cGMP), ANVISA (Brazil B-GMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), French Service-Public (CIR), ANMAT (Argentina nueva GMP), Health Canada (Canada GMP), MHRA (UK GMP), World Health Organization (GMP / HACCP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)

Controlled Substances: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & no medical use, Low potential for abuse, High potential for abuse & medical use

Therapeutic Areas of Expertise (ATC): (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (S) Sensory organs, (R) Respiratory system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism

Category / Product: FDF / DRUG PRODUCTS

Region: Europe

Netherlands

CARBOGEN AMCIS | Veenendaal

CARBOGEN AMCIS

Large scale manufacturing of Cholesterol and Vitamin D analogs.

Discover our facility

Use: Human, Veterinary

BSL (Biological Safety Level): 1

Compliance: DIGEMID, BRCGS, ISO, FDA (cGMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), IFS, Halal Research Council, PMDA/MHLW (Japan GMP), TITCK (Turkish Health Authorities), INVIMA, ECOVADIS, TGA (Australia GMP), ISP (Chile BPM), French Service-Public (CIR), ANMAT (Argentina nueva GMP), NMPA (China GMP), Health Canada (Canada GMP), MHRA (UK GMP), World Health Organization (GMP / HACCP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), NSF, SQF (Safe Quality Food), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)

Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), Russian Health Authorities, CDSCO (India), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), SFDA (Saudi Arabia), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia), Rest of World

Services: Development services, Logistics, Analytical / QC services, Regulatory services, Packaging, Manufacturing services, Quality Assurance services

Therapeutic Areas of Expertise (ATC): (V04) Diagnostic agents, (B) Blood and blood forming organs, (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (S) Sensory organs, (V09-10) Radiopharmaceuticals, (V06) Nutrients, (V01) Allergens, (R) Respiratory system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism

Batch Size: Small

Category / Product: SERVICES, CHEMICAL-SYNTHETIC

Region: Europe

China

CARBOGEN AMCIS | Shanghai, China

CARBOGEN AMCIS

Large scale manufacturing.

Discover our facility

Batch Size: Large, Small, Medium

Use: Human

Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging

Therapeutic Areas of Expertise (ATC): (V04) Diagnostic agents, (D) Dermatologicals, (J) Antiinfectives for systemic use, (B) Blood and blood forming organs, (N) Nervous system, (S) Sensory organs, (V06) Nutrients, (V01) Allergens, (R) Respiratory system, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (C) Cardiovascular system, (A) Digestive tract and metabolism

Compliance: ANVISA (Brazil B-GMP), NMPA (China GMP)

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: SERVICES, CHEMICAL-SYNTHETIC, OLIGONUCLEOTIDES

Region: APAC

Switzerland

CARBOGEN AMCIS | Neuland

CARBOGEN AMCIS

Development and medium scale manufacturing.

Discover our facility

Use: Human, Veterinary

Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), CDSCO (India), MFDS (South Korea), Turkish Health Authorities, TGA (Australia)

Services: Development services, Analytical / QC services, Regulatory services, Manufacturing services, Quality Assurance services

Compliance: FDA (cGMP), PMDA/MHLW (Japan GMP), World Health Organization (GMP / HACCP)

Batch Size: Small, Medium

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: SERVICES, CHEMICAL-SYNTHETIC

Region: Europe

Switzerland

CARBOGEN AMCIS | Bubendorf

CARBOGEN AMCIS

Development and cGMPmanufacturing of Highly Potent API including Antibody Drug Conjugates (ADC).

Discover our facility

Services: Development services, Analytical / QC services, Regulatory services, Quality Assurance services, Manufacturing services

Markets: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), Turkish Health Authorities, CDSCO (India), TGA (Australia)

Compliance: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), EMA (EU GMP), World Health Organization (GMP / HACCP)

Use: Human, Veterinary

Therapeutic Areas of Expertise (ATC): (V09-10) Radiopharmaceuticals, (N) Nervous system, (D) Dermatologicals, (B) Blood and blood forming organs, (R) Respiratory system, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (C) Cardiovascular system, (A) Digestive tract and metabolism

Batch Size: Small, Medium

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: PARTICLE ENGINEERING, SERVICES, BIOLOGICS, CHEMICAL-SYNTHETIC

Region: Europe

Germany

Glatt Pharmaceutical Services GmbH Co. & KG

Your cGMP-compliant CDMO for end-to-end services in the complex oral solids dosage forms field, based in Binzen Germany.

Discover our facility

Batch Size: Large, Small, Medium

Use: Human, Veterinary

BSL (Biological Safety Level): 1

Markets: FDA (USA), EMA (EU)

Services: Development services, Analytical / QC services, Manufacturing services

Compliance: FDA (cGMP), EMA (EU GMP)

Controlled Substances: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & no medical use, Low potential for abuse, High potential for abuse & medical use

Therapeutic Areas of Expertise (ATC): (B) Blood and blood forming organs, (J) Antiinfectives for systemic use, (N) Nervous system, (S) Sensory organs, (V06) Nutrients, (R) Respiratory system, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (C) Cardiovascular system, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: FDF / DRUG PRODUCTS

Region: Europe

Netherlands

Bilthoven Biologicals Drug Substance and Drug Product Facilities

Bilthoven Biologicals BV

Multi-product GMP facilities for Drug Substance and Drug Product.

Discover our facility

Batch Size: Large, Small, Medium

Use: Human

BSL (Biological Safety Level): 1, 2

Markets: EMA (EU), MHRA (UK)

Services: Development services, Logistics, Analytical / QC services, Regulatory services, Packaging, Manufacturing services, Quality Assurance services

Compliance: EMA (EU GMP)

Category / Product: FDF / DRUG PRODUCTS, SERVICES, BIOLOGICS

Region: Europe

Spain

Laboratorios Grifols | Barcelona Plant

Grifols International

Sterile manufacturing solutions (small molecules) in flexible bags and vials.

Discover our facility

Batch Size: Large, Small, Medium

Use: Human, Veterinary

Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), ANMAT (Argentina), TGA (Australia)

Services: Development services, Logistics, Analytical / QC services, Regulatory services, Packaging, Manufacturing services, Quality Assurance services

Compliance: ISO, FDA (cGMP), ANVISA (Brazil B-GMP), INVIMA, ECOVADIS, TGA (Australia GMP), ISP (Chile BPM), ANMAT (Argentina nueva GMP), Health Canada (Canada GMP), MHRA (UK GMP), World Health Organization (GMP / HACCP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

Controlled Substances: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse

Therapeutic Areas of Expertise (ATC): (N) Nervous system, (M) Musculoskeletal system, (C) Cardiovascular system, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: FDF / DRUG PRODUCTS

Region: Europe

Norway

Adragos Pharma | Halden

Adragos Pharma

We specialize in the manufacturing of IV bags, plastic ampoules and vials using Blow-Fill-Seal (BFS) technology and other dosage forms.

Discover our facility

Batch Size: Large, Small, Medium

Use: Human

Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), SFDA (Saudi Arabia), TGA (Australia)

Services: Logistics, Analytical / QC services, Regulatory services, Packaging, Manufacturing services, Quality Assurance services

Compliance: ISO, FDA (cGMP), ANVISA (Brazil B-GMP), PMDA/MHLW (Japan GMP), TITCK (Turkish Health Authorities), TGA (Australia GMP), NMPA (China GMP), MHRA (UK GMP), World Health Organization (GMP / HACCP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), NSF, UAE Ministry of Health & Prevention

Controlled Substances: Lowest potential for abuse, Lower potential for abuse, Low potential for abuse, High potential for abuse & medical use

Therapeutic Areas of Expertise (ATC): (D) Dermatologicals, (V06) Nutrients, (A) Digestive tract and metabolism

OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)

Category / Product: FDF / DRUG PRODUCTS

Region: Europe

More facilities on the network

+82 more facilities

Create free account

Bringing a pharmaceutical product to market requires a partner that can deliver consistent quality at scale. That’s where commercial CDMOs come in. These specialized providers offer the infrastructure, expertise, and regulatory readiness to handle full-scale production, packaging, and distribution—helping you transition seamlessly from development to commercialization.

Whether you’re launching a new drug or scaling up an existing one, commercial contract manufacturing services ensure reliable supply, regulatory compliance, and cost efficiency across global markets.

How to Choose a Commercial Contract Manufacturing Partner

Selecting the right commercial CDMO is crucial for product success. Beyond technical capabilities, look for a partner with:

Executing global market launches via Proven experience: In commercial-scale manufacturing and global launches.

Meeting international health standards through a Regulatory track record: With agencies like the FDA, EMA, and others.

Ensuring continuous product availability via Robust supply chain management: Including sourcing, inventory control, and distribution.

Accommodating fluctuating market demand through Flexible capacity: To support demand fluctuations and future growth.

Maintaining stringent compliance with a Commitment to quality: Through rigorous GMP compliance and continuous improvement systems.

A successful commercial partnership is built on transparency, strategic alignment, and shared long-term goals.

Key Services Offered by Commercial CDMOs

Delivering high-volume drug supply through Full-Scale GMP Manufacturing: High-volume commercial production across a range of dosage forms, including solid, liquid, sterile, and specialty formulations.

Validating late-stage drug processes via Technology Transfer & Process Validation: Transfer of late-stage processes into commercial environments with full validation and documentation.

Securing regulatory-compliant market packaging through Commercial Packaging & Serialization: Blistering, bottling, labeling, and serialization services for regulatory-compliant supply.

Ensuring ongoing commercial batch quality via Stability & Release Testing: Ongoing quality control and ICH-compliant stability programs for commercial batches.

Managing global drug distribution through Global Logistics & Supply Chain Coordination: Warehousing, inventory management, and worldwide distribution solutions.

Advantages of Partnering with a Commercial CDMO

Streamlining technical transfers for an Accelerated Time to Market: Streamlined tech transfer and readiness to launch at scale.

Navigating complex health authority audits for Regulatory Confidence: Commercial CDMOs experienced in audits and submissions for multiple regulatory bodies worldwide.

Driving cost control via Operational Efficiency: Lean manufacturing practices and automation drive cost control and consistency.

Ensuring batch-to-batch consistency for Risk Mitigation: Integrated quality systems reduce supply chain disruptions and ensure product reliability.

Adjusting production outputs to market demand via Scalability: Ability to adjust batch sizes and production schedules based on market demand.

Commercial Manufacturing CDMO Companies

Some of the top commercial CDMO companies:

Actylis: CDMO specialized in Chemical Process Discovery, Development, cGMP, and Commerical Manufacturing Services. [See CDMO profile]

Aenova: CDMO for high volume manufacturing of conventional solids. [See CDMO profile]

CDM Lavoisier: Commercial manufacturing of glass ampoules, glass vials and plastic (BFS) ampoules. [See CDMO profile]

Cambrex: CDMO that develops and manufactures proprietary products (generic APIs) and provides contract manufacturing services for intermediates and custom APIs at commercial scale. [See CDMO profile]

Lannett CDMO: Lannett’s main manufacturing site includes capabilities for Oral Solid Dose (OSD) and Liquids. [See CDMO profile]

Cenexi: CDMO specializing in the commercial production of sterile highly potent injectables, mainly against cancer. [See CDMO profile]

Viswa Laboratories: CRAMS/CDMO, APIs, Intermediates and specialty chemicals. [See CDMO profile]

Pharmaloop: Fully integrated commercial CDMO solutions for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multi-dose, sachets, capsules and tablets. [See CDMO profile]

FAES FARMA: Developer and manufacturer of human medicinal products at commercial scale. [See CDMO profile]

Grifols: Sterile commercial manufacturing solutions (small molecules) in flexible bags and vials. [See CDMO profile]

Pharmaron: Small molecule (RSM/APIs) commercial facility. [See CDMO profile]

VIVUNT PHARMA: CDMO for sterile oncology drugs. [See CDMO profile]

Shilpa Biologicals: CDMO supporting Process Development, Gene to Cell Line Development to GMP to Formulation Development, Analytical Development, Drug Substance Commercial Manufacturing, Drug Product, Fill-Finish and Packaging. [See CDMO profile]

Reig Jofre: Betalactam antibiotics (FDF) development and manufacturing with state-of-the-art facilities. [See CDMO profile]

Mabion: Fully integrated CDMO offering development and GMP manufacturing of biotherapeutics, including commercial manufacturing. [See CDMO profile]

53Biologics: CDMO specialized in decoding biologics production, from DNA to proteins, from preclinical to cGMP commercial manufacturing. [See CDMO profile]

VIVEbiotech: Leading GMP-certified CDMO exclusively dedicated to lentiviral vector production. [See CDMO profile]

HIPRA BIOTECH SERVICES: End-to-end internal capabilities from cell line development to commercial manufacturing. [See CDMO profile]

Skyepharma: Development and delivery of oral technologies serving the global pharmaceutical, biotech and consumer health industries. [See CDMO profile]

Ophtapharm, a Sentiss Company: Ophthalmic and Otic – solutions, suspensions, emulsions, ointments and gels – FDA Approved facility. [See CDMO profile]

CARBOGEN AMCIS: Highly potent APIs development and small-scale cGMP production including chromatography and lyophilization. [See CDMO profile]

Sichuan Huiyu Pharmaceuticals Co., Ltd: Manufacturing and Formulation sites; R&D supporting API and FDF development. [See CDMO profile]

AdhexPharma SAS: CDMO for transdermal patches and oromucosal films. [See CDMO profile]

Apeloa Pharmaceutical Co., Ltd: Development and manufacturing services for APIs, intermediates and registered starting materials. [See CDMO profile]

Glatt Pharmaceutical Services GmbH Co. & KG: cGMP CDMO for end-to-end services in complex oral solid dosage forms. [See CDMO profile]

Lukas Heil-Betriebsstätte: High-performance GMP facility for sterile and aseptic liquids, especially glass ampoules. [See CDMO profile]

Darnytsia Kyiv: CMO with advanced facilities, stringent quality control and expert staff. [See CDMO profile]

Adragos Pharma: Over 100 years of experience delivering first-class service and customer-focused manufacturing. [See CDMO profile]

Cellex Cell Professionals: CGT CDMO with Cell Manufacturing Plant and Collection Center for starting materials. [See CDMO profile]

BAG Health Care: Parenteral F&F provider for vials in small to mid-sized batches and investigational products. [See CDMO profile]

Ascendia Pharmaceutical Solutions: GMP-certified CDMO for sterile and non-sterile manufacturing, formulation development and analytical testing. [See CDMO profile]

MENADIONA S.L: APIs, intermediates and fine chemicals, specialized in scaling R&D into fully cGMP-compliant processes. [See CDMO profile]

i+Med: Developer and manufacturer of new drug products with controlled release technologies. [See CDMO profile]

Liof Pharma S.L.U.: CDMO for aseptic manufacturing and lyophilization of biologics and injectables. [See CDMO profile]

Content Group: Tubilux Pharma: registered office and manufacturing facility. [See CDMO profile]

ChemCon GmbH: Contract development and manufacturing partner for APIs and fine chemicals, specializing in cGMP scale-up. [See CDMO profile]

Sidefarma: Manufacturer of small and medium-sized batches for global regulated markets under EU quality standards. [See CDMO profile]

TRADICHEM INDUSTRIAL SERVICES: HIPERING® Technology – the gateway for lean manufacturing. [See CDMO profile]

Related Information

Let MAI CDMO Help You Find the Right Commercial Manufacturing Partner

Choosing the right commercial CDMO is a strategic decision that impacts your product’s success on the market. MAI CDMO connects you with experienced commercial contract manufacturing partners tailored to your product, scale, and regulatory needs.

We work closely with you to understand your goals and identify commercial CDMOs with the technical capabilities, capacity, and compliance record to meet them.

Contact us today to explore commercial CDMO solutions and ensure your product reaches patients—on time, at scale, and with uncompromised quality.

Commercial CDMO Companies|Commercial Contract Manufacturing Services

Your Trusted Partners for Commercial Contract Manufacturing and Development

Filters

More facilities on the network

Filters

More facilities on the network

How to Choose a Commercial Contract Manufacturing Partner

Key Services Offered by Commercial CDMOs

Advantages of Partnering with a Commercial CDMO

Commercial Manufacturing CDMO Companies

Related Information

Let MAI CDMO Help You Find the Right Commercial Manufacturing Partner

Commercial CDMO Companies|
Commercial Contract Manufacturing Services